Pharma · IBM Heron r2 · ibm_kingston · job da0bkvv2sl0c73bmtf2g
Therapy-only panel. Locked expectation: talaporfin outranks padeliporfin under co-resident efficacy, toxicity, and selectivity.
Choose among five marketed PDT drugs used as therapy. Three goals at once: kill the target, spare tissue, stay selective. Efficacy, toxicity, and selectivity co-reside in one job.
Verify F2-E1: talaporfin (Laserphyrin) > padeliporfin (Tookad) on coupled raw priority, against equal-weight classical.
IBM Heron r2 · ibm_kingston · 4096 shots · job da0bkvv2sl0c73bmtf2g. Transjunctions computed on the QPU. Primary readout: raw counts. Resilience is a labelled diagnostic channel on the same job.
PASS when the locked pair order holds on raw QPC priority. Full ranking is reported. The industry finding is the pair.